VeriMomIs soy isoflavones safe during pregnancy?
Although the CIR review concluded soy‑derived ingredients used in cosmetics are safe as used, multiple peer‑reviewed animal and human biomonitoring studies show isoflavones (particularly genistein/daidzein) have estrogenic activity and have produced developmental/reproductive effects in some animal dosing studies; genistein is also identified as an endocrine‑active substance in ECHA records. Topical cosmetic use is expected to give low but measurable systemic exposure compared with ingestion. (CIR review; PubMed animal/developmental studies; ECHA substance information).
Pregnancy-Safe Alternatives to soy isoflavones | VeriMom
Related ingredients
Frequently asked questions
- Is soy isoflavones safe during pregnancy?
- Although the CIR review concluded soy‑derived ingredients used in cosmetics are safe as used, multiple peer‑reviewed animal and human biomonitoring studies show isoflavones (particularly genistein/daidzein) have estrogenic activity and have produced developmental/reproductive effects in some animal dosing studies; genistein is also identified as an endocrine‑active substance in ECHA records. Topical cosmetic use is expected to give low but measurable systemic exposure compared with ingestion. (CIR review; PubMed animal/developmental studies; ECHA substance information).
- Is soy isoflavones safe while breastfeeding?
- Isoflavones are measurable in human maternal serum and breast milk in studies and have estrogenic activity; animal studies of perinatal exposure report effects on offspring reproductive development, so reproductive concern is present under systemic exposure scenarios. Cosmetic topical use usually results in low systemic exposure, so exposure is low but not zero. (Human biomonitoring and animal studies; CIR; ECHA).
- Is soy isoflavones safe for baby skin?
- Infant/juvenile animal studies with neonatal/perinatal exposure to soy isoflavones (genistein/daidzein) show altered reproductive development; because infant skin has higher absorption/surface‑area‑to‑weight, topical exposure that gives measurable systemic uptake in adults is plausibly moderate in infants (adult e=1 → infant e=2). There are documented measurements of isoflavones in infants following dietary exposure, supporting potential systemic availability. (PubMed neonatal/ developmental studies; biomonitoring reviews).
- How does VeriMom score soy isoflavones?
- VeriMom scores soy isoflavones at 40/100 (medium risk) based on EU CosIng status, ECHA hazard classifications, and peer-reviewed PubMed studies. Our scoring pipeline is fully transparent.
- What are pregnancy-safe alternatives to soy isoflavones?
- See our curated list of pregnancy-safe alternatives to soy isoflavones based on similar function and a no-known-risks safety band.
Check every label in 2 seconds
Get VeriMom free — scan any product and see the pregnancy safety score instantly.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Safety scores are based on publicly available data and may not reflect all risks. Always consult your healthcare provider before using any product during pregnancy or breastfeeding.